Literature DB >> 17571794

Effect of subinhibitory concentration of some established and experimental antifungal compounds on the germ tube formation in Candida albicans.

L A Vale-Silva1, V Buchta, E Valentová.   

Abstract

The influence of subinhibitory concentrations of six established and 19 newly synthesized antifungal compounds on the dimorphic transition of three C. albicans strains was evaluated in the filamentation-inducing medium. Amphotericin B was found to produce almost complete inhibition in the germination at a concentration of 1/10 of the corresponding MIC and partial inhibition at a concentration as low as MIC/50. Flucytosine and four azole derivatives were proven ineffective. From the newly synthesized drugs, the incrustoporin derivative LNO6-22, two phenylguanidine derivatives (PG15, PG45), and four thiosalicylanilide derivatives, in particular, showed results comparable to those of amphotericin B, with a high inhibition of germ tube formation at concentrations of MIC/10. In general, concentrations of MIC/50 had no visible effect.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571794     DOI: 10.1007/BF02932136

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.629


  27 in total

1.  Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis.

Authors:  C Csank; K Schröppel; E Leberer; D Harcus; O Mohamed; S Meloche; D Y Thomas; M Whiteway
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Nonfilamentous C. albicans mutants are avirulent.

Authors:  H J Lo; J R Köhler; B DiDomenico; D Loebenberg; A Cacciapuoti; G R Fink
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

Review 3.  Biology of the pathogenic yeast Candida glabrata.

Authors:  A Bialková; J Subík
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

4.  Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro.

Authors:  F C Odds; S L Cheesman; A B Abbott
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

5.  Vulvovaginal candidiasis is associated with the production of germ tubes by Candida albicans.

Authors:  M E L Consolaro; T A Albertoni; A E Svidzinski; R M Peralta; T I E Svidzinski
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

Review 6.  Dimorphism in fungal pathogens: Candida albicans and Ustilago maydis--similar inputs, different outputs.

Authors:  C Sánchez-Martínez; J Pérez-Martín
Journal:  Curr Opin Microbiol       Date:  2001-04       Impact factor: 7.934

7.  Synthesis and in vitro antifungal activity of 4-substituted phenylguanidinium salts.

Authors:  Gabriela Braunerová; Vladimír Buchta; Luis Silva; Jirí Kunes; Karel Palát
Journal:  Farmaco       Date:  2004-06

8.  Shifting patterns in the epidemiology of nosocomial Candida infections.

Authors:  David R Snydman
Journal:  Chest       Date:  2003-05       Impact factor: 9.410

9.  Deletion of the NOT4 gene impairs hyphal development and pathogenicity in Candida albicans.

Authors:  Karl E Krueger; Anup K Ghosh; Bastiaan P Krom; Ronald L Cihlar
Journal:  Microbiology       Date:  2004-01       Impact factor: 2.777

10.  Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans.

Authors:  K A Hoberg; R L Cihlar; R A Calderone
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

View more
  2 in total

1.  Mutants of Candida albicans hypersensitive to calcofluor white display susceptibility to antifungal drugs.

Authors:  Zhu-Mei He; Jing Chen; Hong-Zhou Li; Di-Qing Luo; Wei Yang
Journal:  Folia Microbiol (Praha)       Date:  2010-05-19       Impact factor: 2.099

2.  Potential of Exopolysaccharide from Porphyridium marinum to Contend with Bacterial Proliferation, Biofilm Formation, and Breast Cancer.

Authors:  Nesrine Gargouch; Fatma Elleuch; Ines Karkouch; Olfa Tabbene; Chantal Pichon; Christine Gardarin; Christophe Rihouey; Luc Picton; Slim Abdelkafi; Imen Fendri; Céline Laroche
Journal:  Mar Drugs       Date:  2021-01-27       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.